The lyme disease spirochete Borrelia burgdorferi utilizes multiple ligands, including RNA, for interferon regulatory factor 3-dependent induction of type I interferon-responsive genes

Infection and Immunity

Volumn 78, Issue 7, 2010, Pages 3144-3153

  Miller, Jennifer C ^a,b   Maylor Hagen, Heather ^a   Ma, Ying ^a   Weis, John H ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERFERON; INTERFERON REGULATORY FACTOR 3; MYELOID DIFFERENTIATION FACTOR 88; NUCLEASE; OUTER SURFACE PROTEIN A; RNA; STAT1 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; JOINT; LYME DISEASE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BORRELIA BURGDORFERI; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NOD2 SIGNALING ADAPTOR PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 77953929145     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01070-09     Document Type: Article

References (53)

1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150. (Pubitemid 28361303)
2. Alverson, J., S. F. Bundle, C. D. Sohaskey, M. C. Lybecker, and D. S. Samuels. 2003. Transcriptional regulation of the ospAB and ospC promters from Borrelia burgdorferi. Mol. Microbiol. 48:1665-1677.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. Current protocols in molecular biology, vol. 1. Wiley Press, New York, NY.
4. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
5. Barbour, A. G., S. L. Tessier, and W. J. Todd. 1983. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect. Immun. 41:795-804.
6. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
7. Behera, A. K., E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu. 2006. MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect. Immun. 74:1462-1470.
8. Bolz, D. D., R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173:2003-2010.
9. Brown, C. R., V. A. Blaho, K. L. Fritsche, and C. M. Loiacono. 2006. Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis. J. Interferon Cytokine Res. 26:390-399.
10. Brown, J. P., J. F. Zachary, C. Teuscher, J. J. Weis, and R. M. Wooten. 1999. Dual role of interleukin-10 in murine lyme disease: regulation of arthritis severity and host defense. Infect. Immun. 67:5142-5150.
11. Charrel-Dennis, M., E. Latz, K. A. Halman, P. Trieu-Cuot, K. A. Fitzgerald, D. L. Kasper, and D. T. Golenbock. 2008. TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 4:543-554. (Pubitemid 352762959)
12. Dennis, V. A., S. Dixit, S. M. O'Brien, X. Alvarez, B. Pahar, and M. T. Philipp. 2009. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect. Immun. 77:1238-1245.
13. Gattorno, M., L. Chicha, A. Gregrio, F. Ferlito, F. Rossi, D. Jarrossay, A. Lanzavecchia, A. Martini, and M. G. Manz. 2007. Distinct expression pattern of IFNa and TNFa in juvenile idiopathic arthritis synovial tissue. Rheumatology 46:657-665. (Pubitemid 46523313)
14. Gratz, N., M. Siller, B. Schaljo, Z. A. Pirzada, I. Gattermeier, I. Vojtek, C. J. Kirschning, H. Wagner, S. Akira, E. Charpentier, and P. Kovarik. 2008. Group A Streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. J. Biol. Chem. 283:19879-19887.
15. Henry, T., A. Brotcke, D. S. Weiss, L. J. Thompson, and D. M. Monack. 2007. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204:987-994.
16. Herskovits, A. A., V. Auerbach, and D. A. Portnoy. 2007. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 3:e51.
17. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-2386. (Pubitemid 29399155)
18. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165:618-622.
19. Jeyaseelan, S., S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen. 2007. Toll/IL-1 receptor domaincontaining adaptor inducing IFN-B (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol. 178:3153-3160.
20. Koga, R., S. Hamano, H. Kuwata, K. Atarashi, M. Ogawa, H. Hisaeda, M. Yamamoto, S. Akira, K. Himeno, M. Matsumoto, and K. Takeda. 2006. TLR-dependent induction of IFN-B mediates host defense against Trypanosoma cruzi. J. Immunol. 177:7059-7066. (Pubitemid 44715073)
21. Kumar, H., T. Kawai, and S. Akira. 2009. Pathogen recognition in the innate immune response. Biochem. J. 420:1-16.
22. Lazarus, J. J., M. A. Kay, A. L. McCarter, and R. M. Wooten. 2008. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect. Immun. 76:1153-1162.
23. Leber, J. H., G. T. Crimmins, S. Raghavan, N. P. Meyer-Morse, J. S. Cox, and D. A. Portnoy. 2008. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4:e6.
24. Liu, N., A. A. Belperron, C. J. Booth, and L. K. Bockenstedt. 2009. The caspase 1 inflammasome is not required for control of murine Lyme borreliosis. Infect. Immun. 77:3320-3327.
25. Liu, N., R. R. Montgomery, S. W. Barthold, and L. K. Bockenstedt. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72:3195-3203.
26. Ma, Y., J. C. Miller, H. Crandall, E. T. Larsen, D. M. Dunn, R. B. Weiss, M. Subramanian, J. H. Weis, J. F. Zachary, C. Teuscher, and J. J. Weis. 2009. Interval-specific congenic lines reveal QTL with penetrant Lyme arthritis phenotypes on chromosomes 5, 11, and 12. Infect. Immun. 77:3302-3311.
27. Ma, Y., K. P. Seiler, K. Tai, L. Yang, M. Woods, and J. J. Weis. 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 62:3663-3671.
28. Mathian, A., A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov. 2005. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black X New Zealand White) F1 but not in BALB/c mice. J. Immunol. 172:2499-2506. (Pubitemid 40279662)
29. Meerpohl, H. G., M. L. Lohmann-Matthes, and H. Fischer. 1976. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF). Eur. J. Immunol. 6:213-217.
30. Miller, J. C., Y. Ma, J. Bian, K. C. F. Sheehan, J. F. Zachary, J. H. Weis, R. D. Schreiber, and J. J. Weis. 2008. A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J. Immunol. 181:8492-8503.
31. Monroe, K. M., S. M. McWhirter, and R. E. Vance. 2009. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog. 5:e1000665.
32. Morrison, T. B., J. J. Weis, and C. T. Wittwer. 1998. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24:954-958, 960, 962.
33. Ornstein, K., and A. G. Barbour. 2006. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector. Vector-Borne Zoonotic Dis. 6:103-112.
34. Pandey, A. K., Y. Yang, Z. Jiang, S. M. Fortune, F. Coulombe, M. A. Behr, K. A. Fitzgerald, C. M. Sassetti, and M. A. Kelliher. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5:e1000500.
35. Petzke, M. M., A. Brooks, M. A. Krupna, D. Mordue, and I. Schwartz. 2009. Recognition of Borrelia burgdorferi, the Lyme disease spirochete by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183:5279-5292.
36. Poltorak, A., X. He, I. Smirnova, M. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in the Tlr4 gene. Science 282:2085-2088.
37. Power, M. R., B. Li, M. Yamamoto, S. Akira, and T. Lin. 2007. A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFNB in the host response to Pseudomonas aeruginosa lung infection in mice. J. Immunol. 178:3170-3176. (Pubitemid 46333199)
38. Salazar, J. C., S. Duhnam-Ems, C. La Vake, A. R. Cruz, M. W. Moore, M. J. Caimano, L. Velez-Climent, J. Shupe, W. Krueger, and J. D. Radolf. 2009. Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFNB. PLoS Pathog. 5:e1000444.
39. Salazar, J. C., C. D. Pope, T. J. Sellati, H. M. Feder, Jr., T. G. Kiely, K. R. Dardick, R. L. Buckman, M. W. Moore, M. J. Caimano, J. G. Pope, P. J. Krause, and J. D. Radolf. 2003. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. J. Immunol. 171:2660-2670.
40. Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos. 2003. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197:777-788.
41. Sato, M., H. Suemori, N. Hata, M. Asagiri, K. Ogasawara, K. Nakao, T. Nakaya, M. Katsuki, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-548.0
42. Schoenfeld, R., B. Araneo, Y. Ma, L. Yang, and J. J. Weis. 1992. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect. Immun. 60:455-464.
43. Stetson, D. B., and R. Medzhitov. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103.
44. Strueby, L., B. Nair, A. Kirk, and R. M. Taylor-Gjevre. 2005. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta. Scand. J. Rheumatol. 34:485-488.
45. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8:907-922.
46. Takayama, K., R. J. Rothenberg, and A. G. Barbour. 1987. Absence of lipopolysaccharide in the Lyme disease spirochete Borrelia burgdorferi. Infect. Immun. 55:2311-2313.
47. Vaena de Avalos, S., I. J. Blader, M. Fisher, J. C. Boothroyd, and B. A. Burleigh. 2002. Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J. Biol. Chem. 277:639-644.
48. n gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162:5666-5670.
49. Wang, G., M. M. Petzke, R. Iyer, H. Wu, and I. Schwartz. 2008. Pattern of proinflammatory cytokine inductine in RAW264.7 mouse macrophages is identical for virulent and attenuated Borrelia burgdorferi. J. Immunol. 180:8306-8315.
50. -/- mice. FEMS Immunol. Med. Microbiol. 52:124-133.
51. Weis, J. J., Y. Ma, and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632-4636.
52. Wilson, L. E., D. Widman, S. H. Dikman, and P. D. Gorevic. 2002. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. 32:163-173.
53. Zhang, T. Y., and R. A. Daynes. 2007. Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J. Immunol. 178:2517-2526.